WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock Forecast, Predictions & Price Target

Analyst price target for ASND

Based on 8 analysts offering 12 month price targets for Ascendis Pharma A.
Min Forecast
$0.40-99.56%
Avg Forecast
$114.80+25.97%
Max Forecast
$192.00+110.69%

Should I buy or sell ASND stock?

Based on 8 analysts offering ratings for Ascendis Pharma A.
Strong Buy
Strong Buy
4 analysts 50%
Buy
2 analysts 25%
Hold
2 analysts 25%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ASND stock forecasts and price targets.

ASND stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Cantor Fitzgerald
Bottom 9%
9
Strong BuyReiterates$152.00+66.79%2023-09-15
Wells Fargo
Top 2%
99
Strong BuyMaintains$134.00+47.04%2023-09-06
Wedbush
Bottom 13%
13
BuyMaintains$192.00+110.69%2023-09-06
Morgan Stanley
Bottom 11%
11
HoldMaintains$113.00+24.00%2023-09-06
Credit Suisse
Bottom 3%
3
HoldAssumes$89.00-2.34%2023-06-14
HC Wainwright & Co.
Bottom 1%
1
BuyMaintains$0.40-99.56%2023-04-18
Citigroup
Bottom 18%
18
Strong BuyMaintains$146.00+60.21%2023-04-05
Bank of America
Top 22%
79
Strong BuyMaintains$92.00+0.95%2023-04-04

1 of 1

Forecast return on equity

Is ASND forecast to generate an efficient return?
Company
N/A
Industry
0.66%
Market
28.71%

Forecast return on assets

Is ASND forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.05%

ASND revenue growth forecast

How is ASND forecast to perform vs Biotechnology companies and vs the US market?
Company
75.3%
Industry
34.31%
Market
8.24%
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ASND's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ASND vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ASND$91.13$114.80+25.97%Strong Buy
ABCM$22.63$23.25+2.74%Buy
HALO$37.69$55.60+47.52%Buy
PCVX$49.04$65.33+33.22%Strong Buy
IMVT$34.64$32.46-6.31%Strong Buy

Ascendis Pharma A Stock Forecast FAQ

Is Ascendis Pharma A Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: ASND) stock is to Strong Buy ASND stock.

Out of 8 analysts, 4 (50%) are recommending ASND as a Strong Buy, 2 (25%) are recommending ASND as a Buy, 2 (25%) are recommending ASND as a Hold, 0 (0%) are recommending ASND as a Sell, and 0 (0%) are recommending ASND as a Strong Sell.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.

What is ASND's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: ASND) forecast ROE is N/A, which is considered weak.

What is ASND's Price Target?

According to 8 Wall Street analysts that have issued a 1 year ASND price target, the average ASND price target is $114.80, with the highest ASND stock price forecast at $192.00 and the lowest ASND stock price forecast at $0.40.

On average, Wall Street analysts predict that Ascendis Pharma A's share price could reach $114.80 by Sep 15, 2024. The average Ascendis Pharma A stock price prediction forecasts a potential upside of 25.97% from the current ASND share price of $91.13.

What is ASND's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: ASND) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.05%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.